Official announcements
Recall
|
Veterinary Medicines
|
23/12/2011
The marketing authorization holder has informed its supplied customers by telephone that the above batch was delivered with Dutch labeling.
Recall
|
Medicines
|
22/12/2011
The marketing authorization holder has informed its supplied customers in a letter dated December 21, 2011, that crystalline particles may be present in the amino acid chamber of the batches listed below and that a recall is therefore being carried…
Recall
|
Medicines
|
22/12/2011
In a letter dated December 12, 2011, the distribution partner informed the institutional pharmacies supplied that the marketing authorization holder was recalling those batches of "Velcade" that were produced at the manufacturer Ben Venue…
Replacement
|
Medicines
|
14/12/2011
The marketing authorization holder has informed its supplied customers by letter dated 14.12.2011 that the above mentioned batches have to be recalled due to a potential contamination with particles. This problem was identified during a GMP…
messages in brief
|
06/12/2011
This ordinance serves to implement the power to issue ordinances under Section 12a(2) of the Health and Food Safety Act. It regulates the detailed modalities of the levy, the parties obliged to pay the levy, details of the collection procedure and…
Safety warnings
|
Blood & Tissue
|
05/12/2011
Removal of donor selection for various provinces.
messages in brief
|
30/11/2011
The illegally sold and used drug Ukrain, which is advertised as a remedy against cancer, may not be manufactured and sold in Austria for the protection of patients. In addition, individual importation into Austria was prohibited by notice and use…
Recall
|
Medicines
|
28/11/2011
The marketing authorization holder has informed the supplied customers by letter dated November 28, 2011, that a GMP inspection of the manufacturer Ben Venue Laboratories (BVL) in Ohio/USA identified quality assurance deficiencies. As a precautionary…
Replacement
|
Medicines
|
25/11/2011
The distributor has informed the supplied institutional pharmacies in a letter dated November 25, 2011, that a GMP inspection of the manufacturer Ben Venue Laboratories (BVL) in Ohio/USA has identified deficiencies in quality assurance. As a…
Replacement
|
Medicines
|
16/11/2011
The marketing authorization holder informed its supplied customers in a letter dated November 14, 2011, that there was misinformation in the instructions for use regarding the appearance of the tablets: the description reads salmon-colored oval…
